CompletedNot Applicable

Extracorporeal Shockwave Therapy in Insertional Achilles Tendinopathy

30 participantsStarted 2016-07-04

Plain-language summary

There is still limited number of studies in the literature provides insufficient evidence to support the use of ESWT in the treatment of insertional Achilles tendinopathy and the contribution of a placebo effect to the shock waves was not assessed by previous study. So the investigators conducted a double-blinded randomized-controlled trial at the orthopedic out-patient clinic, Department of Orthopedics, Faculty of Medicine Ramathibodi Hospital between December 2016 and June 2018. Hypothesized that ESWT might be effective on insertional Achilles tendinopathy

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosed as insertional Achilles tendinopathy * Have symptom at least 6 months * Willing to participate Exclusion Criteria: * History of peritendinous steroid injections within 4 weeks * Neurological conditions * Local skin infection * Ankle arthritis, traumatic, inflammation or deformity of ankle * History of ankle surgery * Contraindication for ESWT : Hemophilia, Coagulopathy

What they're measuring

Visual Analog Scale

Timeframe: Up to 24 weeks

Trial details

NCT IDNCT03683641

SponsorMahidol University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2018-06-28

View on ClinicalTrials.gov More Insertional Achilles Tendinopathy trials